{"transactions":[{"id":703627,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-25T00:07:54.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":571286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and, thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean July 24, 2026."}],"balance_after":571286,"derivative":{"exercise_price":5.19,"expiration_date":"2036-07-23","underlying":"Common Stock","underlying_shares":571286},"source":{"system":"sec-edgar","filing":"0001193125-26-316544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526316544/ownership.xml","form_type":"4"}},{"id":703626,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-07-25T00:07:54.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2312138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date, twenty percent (20%) of the RSUs subject to the award shall vest on the one year anniversary of the grant date, twenty percent (20%) of the RSUs subject to the award shall vest on the two year anniversary of the grant date, and 60% of the RSUs subject to the award shall vest on the three year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Inducement Equity Incentive Plan) through each applicable date, twenty percent (20%) of the RSUs subject to the award shall vest on the one year anniversary of the grant date, twenty percent (20%) of the RSUs subject to the award shall vest on the two year anniversary of the grant date, and 60% of the RSUs subject to the award shall vest on the three year anniversary of the grant date."}],"balance_after":2312138,"derivative":{"underlying":"Common Stock","underlying_shares":2312138},"source":{"system":"sec-edgar","filing":"0001193125-26-316544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526316544/ownership.xml","form_type":"4"}},{"id":833580,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T23:04:18.000Z","date":"2026-03-19","kind":"sale","planned":false,"acquired":false,"shares":4440,"price":67,"value":297480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":61480,"source":{"system":"sec-edgar","filing":"0001788542-26-000007","document":"wk-form4_1773961455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000007/wk-form4_1773961455.xml","form_type":"4"}},{"id":833579,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T23:04:18.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":4330,"price":68.71,"value":297514.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":65920,"source":{"system":"sec-edgar","filing":"0001788542-26-000007","document":"wk-form4_1773961455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000007/wk-form4_1773961455.xml","form_type":"4"}},{"id":833578,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T23:04:18.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":4286,"price":69.42,"value":297534.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":70250,"source":{"system":"sec-edgar","filing":"0001788542-26-000007","document":"wk-form4_1773961455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000007/wk-form4_1773961455.xml","form_type":"4"}},{"id":838205,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:32:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":5524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service."}],"balance_after":16574,"derivative":{"underlying":"Common Stock","underlying_shares":5524},"source":{"system":"sec-edgar","filing":"0001788542-26-000005","document":"wk-form4_1773779561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000005/wk-form4_1773779561.xml","form_type":"4"}},{"id":838204,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:32:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."}],"balance_after":16040,"derivative":{"underlying":"Common Stock","underlying_shares":8020},"source":{"system":"sec-edgar","filing":"0001788542-26-000005","document":"wk-form4_1773779561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000005/wk-form4_1773779561.xml","form_type":"4"}},{"id":838203,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:32:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."}],"balance_after":8148,"derivative":{"underlying":"Common Stock","underlying_shares":8148},"source":{"system":"sec-edgar","filing":"0001788542-26-000005","document":"wk-form4_1773779561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000005/wk-form4_1773779561.xml","form_type":"4"}},{"id":838202,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:32:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs vested on March 15th of each of 2023, 2024, 2025 and 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs vested on March 15th of each of 2023, 2024, 2025 and 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4790},"source":{"system":"sec-edgar","filing":"0001788542-26-000005","document":"wk-form4_1773779561.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000005/wk-form4_1773779561.xml","form_type":"4"}},{"id":838201,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:32:44.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":26482,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 497 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025."}],"balance_after":74536,"source":{"system":"sec-edgar","filing":"0001788542-26-000005","document":"wk-form4_1773779561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000005/wk-form4_1773779561.xml","form_type":"4"}},{"id":853671,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-09T20:06:44.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":19306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service."}],"balance_after":19306,"derivative":{"underlying":"Common Stock","underlying_shares":19306},"source":{"system":"sec-edgar","filing":"0001788542-26-000003","document":"wk-form4_1773086801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000003/wk-form4_1773086801.xml","form_type":"4"}},{"id":853670,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-09T20:06:44.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":30724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 5, 2027, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service."}],"balance_after":30724,"derivative":{"exercise_price":74.9,"expiration_date":"2036-03-04","underlying":"Common Stock","underlying_shares":30724},"source":{"system":"sec-edgar","filing":"0001788542-26-000003","document":"wk-form4_1773086801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854226000003/wk-form4_1773086801.xml","form_type":"4"}},{"id":1115150,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T20:50:49.000Z","date":"2025-06-09","kind":"sale","planned":true,"acquired":false,"shares":17500,"price":43.76,"value":765800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $43.42 to $44.55. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the\nSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":47557,"source":{"system":"sec-edgar","filing":"0001819790-25-000081","document":"wk-form4_1749675042.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000081/wk-form4_1749675042.xml","form_type":"4"}},{"id":1195802,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-21T01:49:54.000Z","date":"2025-03-20","kind":"sale","planned":false,"acquired":false,"shares":3365,"price":50.11,"value":168620.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":65057,"source":{"system":"sec-edgar","filing":"0001819790-25-000059","document":"wk-form4_1742521788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000059/wk-form4_1742521788.xml","form_type":"4"}},{"id":1195801,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-21T01:49:54.000Z","date":"2025-03-19","kind":"sale","planned":false,"acquired":false,"shares":3557,"price":47.4,"value":168601.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":68422,"source":{"system":"sec-edgar","filing":"0001819790-25-000059","document":"wk-form4_1742521788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000059/wk-form4_1742521788.xml","form_type":"4"}},{"id":1195800,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-21T01:49:54.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":3643,"price":46.29,"value":168634.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":71979,"source":{"system":"sec-edgar","filing":"0001819790-25-000059","document":"wk-form4_1742521788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000059/wk-form4_1742521788.xml","form_type":"4"}},{"id":1200196,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T01:38:49.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service."}],"balance_after":24060,"derivative":{"underlying":"Common Stock","underlying_shares":8019},"source":{"system":"sec-edgar","filing":"0001819790-25-000042","document":"wk-form4_1742348322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000042/wk-form4_1742348322.xml","form_type":"4"}},{"id":1200195,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T01:38:49.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."}],"balance_after":16296,"derivative":{"underlying":"Common Stock","underlying_shares":8148},"source":{"system":"sec-edgar","filing":"0001819790-25-000042","document":"wk-form4_1742348322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000042/wk-form4_1742348322.xml","form_type":"4"}},{"id":1200194,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-19T01:38:49.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":4790,"derivative":{"underlying":"Common Stock","underlying_shares":4790},"source":{"system":"sec-edgar","filing":"0001819790-25-000042","document":"wk-form4_1742348322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000042/wk-form4_1742348322.xml","form_type":"4"}},{"id":1200193,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-19T01:38:49.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":true,"shares":20957,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 590 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2024 and December 31, 2024."}],"balance_after":75622,"source":{"system":"sec-edgar","filing":"0001819790-25-000042","document":"wk-form4_1742348322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000042/wk-form4_1742348322.xml","form_type":"4"}},{"id":1217582,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-07T21:19:23.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":22098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service."}],"balance_after":22098,"derivative":{"underlying":"Common Stock","underlying_shares":22098},"source":{"system":"sec-edgar","filing":"0001819790-25-000026","document":"wk-form4_1741382357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000026/wk-form4_1741382357.xml","form_type":"4"}},{"id":1217581,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T21:19:23.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":33691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option  shares shall vest on March 5, 2026, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service."}],"balance_after":33691,"derivative":{"exercise_price":44.54,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":33691},"source":{"system":"sec-edgar","filing":"0001819790-25-000026","document":"wk-form4_1741382357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979025000026/wk-form4_1741382357.xml","form_type":"4"}},{"id":1569189,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-19T23:08:33.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":8148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service."}],"balance_after":24444,"derivative":{"underlying":"Common Stock","underlying_shares":8148},"source":{"system":"sec-edgar","filing":"0001819790-24-000047","document":"wk-form4_1710889691.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000047/wk-form4_1710889691.xml","form_type":"4"}},{"id":1569188,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-19T23:08:33.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":false,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":9580,"derivative":{"underlying":"Common Stock","underlying_shares":4790},"source":{"system":"sec-edgar","filing":"0001819790-24-000047","document":"wk-form4_1710889691.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000047/wk-form4_1710889691.xml","form_type":"4"}},{"id":1569187,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-19T23:08:33.000Z","date":"2024-03-18","kind":"sale","planned":false,"acquired":false,"shares":4766,"price":30.6,"value":145839.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":54075,"source":{"system":"sec-edgar","filing":"0001819790-24-000047","document":"wk-form4_1710889691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000047/wk-form4_1710889691.xml","form_type":"4"}},{"id":1569186,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-19T23:08:33.000Z","date":"2024-03-15","kind":"exercise","planned":false,"acquired":true,"shares":12938,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 97 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2023."}],"balance_after":58841,"source":{"system":"sec-edgar","filing":"0001819790-24-000047","document":"wk-form4_1710889691.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000047/wk-form4_1710889691.xml","form_type":"4"}},{"id":1584377,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-11T21:12:36.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":32079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027, and 2028, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027, and 2028, subject to the Reporting Person's continuous service."}],"balance_after":32079,"derivative":{"underlying":"Common Stock","underlying_shares":32079},"source":{"system":"sec-edgar","filing":"0001819790-24-000034","document":"wk-form4_1710191542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000034/wk-form4_1710191542.xml","form_type":"4"}},{"id":1584376,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-11T21:12:36.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":47500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 7, 2025, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":47500,"derivative":{"exercise_price":35.5,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001819790-24-000034","document":"wk-form4_1710191542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979024000034/wk-form4_1710191542.xml","form_type":"4"}},{"id":1824925,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-07-21T21:46:51.000Z","date":"2023-07-19","kind":"sale","planned":true,"acquired":false,"shares":2400,"price":20.05,"value":48120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $20.00 to $20.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 120 shares acquired under the Issuer's employee stock purchase plan on June 30, 2023."}],"balance_after":45806,"source":{"system":"sec-edgar","filing":"0001788542-23-000006","document":"wk-form4_1689976000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854223000006/wk-form4_1689976000.xml","form_type":"4"}},{"id":1858982,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-06-12T21:25:40.000Z","date":"2023-06-08","kind":"sale","planned":true,"acquired":false,"shares":100,"price":20,"value":2000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022."}],"balance_after":48086,"source":{"system":"sec-edgar","filing":"0001209191-23-036395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123036395/doc4.xml","form_type":"4"}},{"id":1862582,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-06-08T23:16:24.000Z","date":"2023-06-07","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":19.34,"value":48350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $19.02 to $19.62. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":48186,"source":{"system":"sec-edgar","filing":"0001209191-23-035579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123035579/doc4.xml","form_type":"4"}},{"id":1862581,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-06-08T23:16:24.000Z","date":"2023-06-06","kind":"sale","planned":true,"acquired":false,"shares":2143,"price":18.61,"value":39881.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.07 to $18.86. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50686,"source":{"system":"sec-edgar","filing":"0001209191-23-035579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123035579/doc4.xml","form_type":"4"}},{"id":1940274,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:46:10.000Z","date":"2023-03-23","kind":"sale","planned":false,"acquired":false,"shares":372,"price":12.15,"value":4519.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":52829,"source":{"system":"sec-edgar","filing":"0001788542-23-000004","document":"wf-form4_167961515955541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854223000004/wf-form4_167961515955541.xml","form_type":"4"}},{"id":1940273,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:46:10.000Z","date":"2023-03-22","kind":"sale","planned":false,"acquired":false,"shares":357,"price":12.64,"value":4512.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":53201,"source":{"system":"sec-edgar","filing":"0001788542-23-000004","document":"wf-form4_167961515955541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854223000004/wf-form4_167961515955541.xml","form_type":"4"}},{"id":1940272,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-23T23:46:10.000Z","date":"2023-03-21","kind":"sale","planned":false,"acquired":false,"shares":349,"price":12.89,"value":4498.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":53558,"source":{"system":"sec-edgar","filing":"0001788542-23-000004","document":"wf-form4_167961515955541.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854223000004/wf-form4_167961515955541.xml","form_type":"4"}},{"id":1943211,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T23:08:45.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":358,"price":12.61,"value":4514.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":53907,"source":{"system":"sec-edgar","filing":"0001788542-23-000002","document":"wf-form4_167944011481271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854223000002/wf-form4_167944011481271.xml","form_type":"4"}},{"id":1943210,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T23:08:45.000Z","date":"2023-03-17","kind":"sale","planned":false,"acquired":false,"shares":339,"price":13.28,"value":4501.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":54265,"source":{"system":"sec-edgar","filing":"0001788542-23-000002","document":"wf-form4_167944011481271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854223000002/wf-form4_167944011481271.xml","form_type":"4"}},{"id":1947332,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-17T22:17:06.000Z","date":"2023-03-15","kind":"exercise","acquired":false,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan.  25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"RSU granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan.  25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":14370,"derivative":{"underlying":"Common Stock","underlying_shares":4790},"source":{"system":"sec-edgar","filing":"0001209191-23-019879","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123019879/doc4.xml","form_type":"4"}},{"id":1947331,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-17T22:17:06.000Z","date":"2023-03-16","kind":"sale","acquired":false,"shares":336,"price":13.43,"value":4512.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":54604,"source":{"system":"sec-edgar","filing":"0001209191-23-019879","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123019879/doc4.xml","form_type":"4"}},{"id":1947330,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-17T22:17:06.000Z","date":"2023-03-15","kind":"exercise","acquired":true,"shares":4790,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 421 shares acquired under the Issuer's employee stock purchase plan on December 31, 2022."}],"balance_after":54940,"source":{"system":"sec-edgar","filing":"0001209191-23-019879","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123019879/doc4.xml","form_type":"4"}},{"id":1958975,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-11T00:25:25.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":32592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026, and 2027, subject to the Reporting Person's continuous service."}],"balance_after":32592,"derivative":{"underlying":"Common Stock","underlying_shares":32592},"source":{"system":"sec-edgar","filing":"0001209191-23-017999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123017999/doc4.xml","form_type":"4"}},{"id":1958974,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-11T00:25:25.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":48116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 8, 2024, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":48116,"derivative":{"exercise_price":15,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":48116},"source":{"system":"sec-edgar","filing":"0001209191-23-017999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919123017999/doc4.xml","form_type":"4"}},{"id":2112391,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-17T22:30:33.000Z","date":"2022-11-15","kind":"sale","acquired":false,"shares":6857,"price":17.72,"value":121506.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $17.44 to $18.18. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":49729,"source":{"system":"sec-edgar","filing":"0001788542-22-000006","document":"wf-form4_166872420553318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854222000006/wf-form4_166872420553318.xml","form_type":"4"}},{"id":2172992,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-08-26T20:25:25.000Z","date":"2022-08-24","kind":"exercise","acquired":false,"shares":772,"price":0.45,"value":347.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted under the Plan. 25% of the option shares vested and became exercisable on July 27, 2019 and the remaining option shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":0.45,"expiration_date":"2028-09-13","underlying":"Common Stock","underlying_shares":772},"source":{"system":"sec-edgar","filing":"0001788542-22-000004","document":"wf-form4_166154550807584.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854222000004/wf-form4_166154550807584.xml","form_type":"4"}},{"id":2172991,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-08-26T20:25:25.000Z","date":"2022-08-24","kind":"exercise","acquired":false,"shares":4416,"price":10.99,"value":48531.84,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option granted under the Tarsus Pharmaceuticals, Inc. 2016 Stock Plan (the \"Plan\"). The option shares vest and become exercisable in 48 equal monthly installments beginning on October 25, 2020."}],"balance_after":10573,"derivative":{"exercise_price":10.99,"expiration_date":"2030-09-24","underlying":"Common Stock","underlying_shares":4416},"source":{"system":"sec-edgar","filing":"0001788542-22-000004","document":"wf-form4_166154550807584.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854222000004/wf-form4_166154550807584.xml","form_type":"4"}},{"id":2172990,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-26T20:25:25.000Z","date":"2022-08-24","kind":"exercise","acquired":true,"shares":772,"price":0.45,"value":347.4,"ownership":{"direct":true},"balance_after":56586,"source":{"system":"sec-edgar","filing":"0001788542-22-000004","document":"wf-form4_166154550807584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854222000004/wf-form4_166154550807584.xml","form_type":"4"}},{"id":2172989,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-26T20:25:25.000Z","date":"2022-08-24","kind":"exercise","acquired":true,"shares":4416,"price":10.99,"value":48531.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 470 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021, and includes 725 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022."}],"balance_after":55814,"source":{"system":"sec-edgar","filing":"0001788542-22-000004","document":"wf-form4_166154550807584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854222000004/wf-form4_166154550807584.xml","form_type":"4"}},{"id":2337810,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-11T21:10:25.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":19160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service."}],"balance_after":19160,"derivative":{"underlying":"Common Stock","underlying_shares":19160},"source":{"system":"sec-edgar","filing":"0001788542-22-000002","document":"wf-form4_164703293653715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854222000002/wf-form4_164703293653715.xml","form_type":"4"}},{"id":2337809,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-11T21:10:25.000Z","date":"2022-03-09","kind":"grant","acquired":true,"shares":65312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on March 9, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service."}],"balance_after":65312,"derivative":{"exercise_price":19.59,"expiration_date":"2032-03-08","underlying":"Common Stock","underlying_shares":65312},"source":{"system":"sec-edgar","filing":"0001788542-22-000002","document":"wf-form4_164703293653715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000178854222000002/wf-form4_164703293653715.xml","form_type":"4"}},{"id":2518015,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-10T23:29:55.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":1889,"price":28.11,"value":53099.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $28.00 to $28.56. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50203,"source":{"system":"sec-edgar","filing":"0001819790-21-000055","document":"wf-form4_163658697878613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000055/wf-form4_163658697878613.xml","form_type":"4"}},{"id":2521556,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-08T22:49:29.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":11,"price":28.11,"value":309.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021."}],"balance_after":52092,"source":{"system":"sec-edgar","filing":"0001819790-21-000047","document":"wf-form4_163641175289229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000047/wf-form4_163641175289229.xml","form_type":"4"}},{"id":2521555,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-08T22:49:29.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":100,"price":28.03,"value":2803.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021."}],"balance_after":52103,"source":{"system":"sec-edgar","filing":"0001819790-21-000047","document":"wf-form4_163641175289229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000047/wf-form4_163641175289229.xml","form_type":"4"}},{"id":2524706,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-04T23:03:41.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":542,"price":27.071,"value":14672.482,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $27.020 to $27.730. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":52203,"source":{"system":"sec-edgar","filing":"0001819790-21-000045","document":"wf-form4_163606700536434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000045/wf-form4_163606700536434.xml","form_type":"4"}},{"id":2524705,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-11-04T23:03:41.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":5458,"price":26.753,"value":146017.874,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.020 to $27.015. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":52745,"source":{"system":"sec-edgar","filing":"0001819790-21-000045","document":"wf-form4_163606700536434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000045/wf-form4_163606700536434.xml","form_type":"4"}},{"id":2571025,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-14T20:51:01.000Z","date":"2021-09-10","kind":"exercise","acquired":false,"shares":2593,"price":0.45,"value":1166.85,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted under the Plan. 25% of the option shares vested and became exercisable on July 27, 2019 and the remaining option shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":772,"derivative":{"exercise_price":0.45,"expiration_date":"2028-09-13","underlying":"Common Stock","underlying_shares":2593},"source":{"system":"sec-edgar","filing":"0001819790-21-000031","document":"wf-form4_163165264472878.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000031/wf-form4_163165264472878.xml","form_type":"4"}},{"id":2571024,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-14T20:51:01.000Z","date":"2021-09-10","kind":"exercise","acquired":false,"shares":4350,"price":10.99,"value":47806.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option granted under the Tarsus Pharmaceuticals, Inc. 2016 Stock Plan (the \"Plan\"). The option shares vest and become exercisable in 48 equal monthly installments beginning on October 25, 2020."}],"balance_after":14989,"derivative":{"exercise_price":10.99,"expiration_date":"2030-09-24","underlying":"Common Stock","underlying_shares":4350},"source":{"system":"sec-edgar","filing":"0001819790-21-000031","document":"wf-form4_163165264472878.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000031/wf-form4_163165264472878.xml","form_type":"4"}},{"id":2571023,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-14T20:51:01.000Z","date":"2021-09-10","kind":"sale","acquired":false,"shares":2593,"price":22.15,"value":57434.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $22.000 to $22.200. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":58203,"source":{"system":"sec-edgar","filing":"0001819790-21-000031","document":"wf-form4_163165264472878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000031/wf-form4_163165264472878.xml","form_type":"4"}},{"id":2571022,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-14T20:51:01.000Z","date":"2021-09-10","kind":"exercise","acquired":true,"shares":2593,"price":0.45,"value":1166.85,"ownership":{"direct":true},"balance_after":60796,"source":{"system":"sec-edgar","filing":"0001819790-21-000031","document":"wf-form4_163165264472878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000031/wf-form4_163165264472878.xml","form_type":"4"}},{"id":2571021,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2021-09-14T20:51:01.000Z","date":"2021-09-10","kind":"exercise","acquired":true,"shares":4350,"price":10.99,"value":47806.5,"ownership":{"direct":true},"balance_after":58203,"source":{"system":"sec-edgar","filing":"0001819790-21-000031","document":"wf-form4_163165264472878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979021000031/wf-form4_163165264472878.xml","form_type":"4"}},{"id":2912424,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":28833,"kind":"person","name":"Mottiwala Aziz","position":1,"cik":"0001788542","reported_name":"Mottiwala Aziz","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-08T21:55:12.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":40999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest on January 7, 2022, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years."}],"balance_after":40999,"derivative":{"exercise_price":47.25,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":40999},"source":{"system":"sec-edgar","filing":"0001209191-21-002741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000120919121002741/doc4.xml","form_type":"4"}}]}